av/sorrento-therapeutics--big.svg

NASDAQ:SRNE

Sorrento Therapeutics, Inc.

  • Stock

USD

Last Close

0.00

08/11 20:00

Market Cap

6.06M

Beta: -

Volume Today

8.40K

Avg: 36.50M

PE Ratio

−0.25

PFCF: −0.62

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
1.68M
-
2.60M
54.46%
4.97M
91.35%
9.04M
81.97%
average payables
1.30M
-
1.90M
46.91%
1.50M
21.39%
4.81M
221.24%
9.10M
89.10%
11.86M
30.42%
20.72M
74.68%
26.17M
26.27%
26.06M
0.41%
37.46M
43.76%
average receivables
237.00K
-
563.12K
137.60%
1.68M
197.45%
2.80M
67.25%
3.46M
23.34%
4.14M
19.88%
9.44M
127.79%
15.01M
59.07%
17.11M
14.00%
21.59M
26.19%
book value per share
4.44
-
4.07
8.23%
3.93
3.49%
1.59
59.59%
2.86
80.05%
1.97
31.04%
0.59
70.00%
0.72
21.37%
0.27
62.82%
-0.04
116.61%
capex per share
-0.06
-
-0.02
64.21%
-0.10
353.39%
-0.14
35.63%
-0.16
15.49%
-0.11
32.96%
-0.09
18.26%
-0.16
89.68%
-0.03
81.60%
-0.03
8.23%
capex to depreciation
-0.72
-
-0.19
74.28%
-1.56
742.67%
-2.38
52.02%
-1.55
34.82%
-1.24
20.22%
-1.04
15.79%
-3.41
227.89%
-0.71
79.15%
-1.03
44.85%
capex to operating cash flow
0.06
-
0.02
63.62%
0.09
328.87%
0.10
9.82%
0.11
14.32%
0.10
9.46%
0.07
33.97%
0.24
256.14%
0.03
86.64%
0.05
47.65%
capex to revenue
-2.02
-
-0.15
92.37%
-0.81
422.70%
-0.84
4.20%
-0.07
91.41%
-0.53
631.10%
-0.36
31.09%
-0.94
158.17%
-0.17
82.16%
-0.22
29.61%
cash per share
2.10
-
2.70
28.05%
3.70
37.13%
1.66
55.13%
0.30
81.95%
1.50
400.66%
0.17
88.67%
0.25
44.80%
0.43
75.20%
0.12
72.31%
days of inventory on hand
100.28
-
67.23
32.95%
227.05
237.70%
108.85
52.06%
days payables outstanding
177.06K
-
295.86
99.83%
250.63
15.29%
3.73K
1,387.20%
916.99
75.40%
714.33
22.10%
824.14
15.37%
907.21
10.08%
767.87
15.36%
518.44
32.48%
days sales outstanding
312.73
-
69.85
77.66%
208.19
198.04%
133.65
35.80%
9.44
92.94%
75.07
695.57%
168.53
124.49%
141.54
16.01%
129.12
8.78%
142.13
10.07%
debt to assets
0.28
-
0.23
16.68%
0.59
154.26%
0.78
33.05%
0.52
33.56%
0.67
28.05%
0.94
41.01%
0.74
21.66%
0.89
20.37%
0.28
67.95%
debt to equity
0.39
-
0.30
21.72%
1.40
362.18%
3.94
182.07%
1.13
71.36%
1.99
76.39%
6.68
235.83%
2.39
64.18%
7.83
227.35%
-7.23
192.32%
dividend yield
earnings yield
-0.18
-
-0.13
28.25%
-0.14
10.47%
-0.25
73.25%
0.03
113.96%
-0.80
2,418.63%
-0.65
18.52%
-0.19
70.77%
-0.31
64.23%
-1.51
381.80%
enterprise value
95.01M
-
208.90M
119.88%
291.67M
39.62%
211.68M
27.42%
249.80M
18.01%
329.31M
31.83%
716.90M
117.70%
1.68B
134.55%
1.57B
6.53%
482.38M
69.31%
enterprise value over ebitda
-4.66
-
-6.62
41.96%
-53.27
704.47%
-3.69
93.07%
-16.83
355.63%
-2.30
86.33%
-2.92
26.96%
-6.24
113.75%
-3.58
42.69%
-1.32
63.02%
ev to operating cash flow
-5.76
-
-7.26
26.05%
-6.93
4.54%
-2.99
56.93%
-2.52
15.65%
-2.95
16.98%
-4.14
40.65%
-10.54
154.34%
-5.58
47.09%
-1.64
70.56%
ev to sales
206.47
-
54.61
73.55%
63.54
16.35%
25.97
59.14%
1.64
93.67%
15.54
844.60%
22.81
46.78%
42.05
84.37%
29.71
29.36%
7.68
74.16%
free cash flow per share
-1.16
-
-1.10
4.97%
-1.24
12.72%
-1.54
24.49%
-1.58
2.30%
-1.16
26.66%
-1.39
19.96%
-0.86
38.28%
-0.99
14.98%
-0.73
25.63%
free cash flow yield
-0.14
-
-0.11
23.56%
-0.14
30.32%
-0.32
121.28%
-0.42
31.91%
-0.48
16.12%
-0.41
14.82%
-0.13
69.43%
-0.21
68.76%
-0.83
290.30%
graham net net
0.41
-
1.49
261.02%
-1.74
217.14%
-4.55
161.76%
-2.88
36.66%
-2.40
16.96%
-3.69
54.04%
-1.42
61.55%
-1.60
12.79%
-1.00
37.23%
graham number
12.06
-
10.91
9.53%
10.48
3.97%
6.58
37.24%
2.90
55.85%
9.23
217.79%
5.41
41.32%
4.58
15.37%
2.96
35.50%
1.15
60.95%
income quality
0.75
-
0.83
10.28%
0.84
1.23%
1.11
31.98%
-8.93
905.20%
0.53
105.89%
0.48
9.38%
0.51
6.47%
0.66
29.42%
0.51
22.55%
intangibles to total assets
0.62
-
0.39
37.26%
0.07
81.62%
0.26
270.62%
0.25
4.33%
0.17
33.83%
0.18
8.73%
0.22
20.07%
0.49
123.16%
0.46
5.93%
interest coverage
-85.58
-
-21.33
75.08%
-44.80
110.05%
-60.11
34.18%
5.09
108.46%
-2.61
151.31%
-7.18
174.99%
-12.12
68.81%
-39.27
224.07%
-44.15
12.43%
interest debt per share
0.34
-
0.52
53.59%
0.29
42.90%
0.97
229.55%
0.15
84.96%
2.74
1,775.54%
2.46
10.13%
0.82
66.51%
0.84
1.91%
0.34
59.41%
inventory turnover
3.64
-
5.43
49.15%
1.61
70.39%
3.35
108.59%
invested capital
0.07
-
0.11
55.35%
0.06
43.09%
0.59
829.79%
0.03
95.58%
1.11
4,165.13%
3.70
232.24%
1.03
72.28%
3.02
194.14%
-7.23
339.63%
market cap
121.87M
-
268.66M
120.45%
321.48M
19.66%
246.76M
23.24%
265.02M
7.40%
254.76M
3.87%
448.63M
76.10%
1.57B
249.63%
1.37B
12.61%
371.51M
72.90%
net current asset value
6.86M
-
41.09M
499.02%
-61.56M
249.84%
-225.43M
266.18%
-195.30M
13.36%
-237.02M
21.36%
-457.29M
92.93%
-308.86M
32.46%
-443.70M
43.66%
-398.14M
10.27%
net debt to ebitda
1.32
-
1.89
43.63%
5.44
187.43%
0.61
88.76%
1.02
67.48%
-0.52
150.81%
-1.09
109.87%
-0.42
61.64%
-0.46
9.09%
-0.30
33.52%
net income per share
-1.46
-
-1.30
10.80%
-1.24
4.45%
-1.21
2.53%
0.13
110.82%
-1.92
1,564.40%
-2.20
14.76%
-1.30
40.98%
-1.45
11.89%
-1.33
8.20%
operating cash flow per share
-1.10
-
-1.08
1.63%
-1.14
5.72%
-1.41
23.50%
-1.42
1.02%
-1.05
25.96%
-1.30
23.78%
-0.69
46.74%
-0.96
37.73%
-0.70
26.70%
payables turnover
0.00
-
1.23
59,747.58%
1.46
18.04%
0.10
93.28%
0.40
306.48%
0.51
28.37%
0.44
13.32%
0.40
9.16%
0.48
18.15%
0.70
48.11%
receivables turnover
1.17
-
5.23
347.70%
1.75
66.45%
2.73
55.77%
38.68
1,316.32%
4.86
87.43%
2.17
55.45%
2.58
19.07%
2.83
9.62%
2.57
9.15%
research and ddevelopement to revenue
19.60
-
6.27
68.00%
6.83
8.91%
5.17
24.24%
0.37
92.93%
3.63
893.07%
3.40
6.37%
2.78
18.11%
3.91
40.47%
3.52
9.99%
return on tangible assets
-0.62
-
-0.40
35.62%
-0.14
64.14%
-0.21
43.67%
0.03
113.73%
-0.39
1,482.79%
-0.64
63.47%
-0.71
11.33%
-1.20
68.94%
-2.19
81.62%
revenue per share
0.03
-
0.14
368.79%
0.12
13.26%
0.16
30.17%
2.18
1,245.11%
0.20
90.83%
0.24
18.61%
0.17
26.53%
0.18
3.15%
0.15
16.50%
roe
-0.33
-
-0.32
2.80%
-0.32
1.00%
-0.76
141.18%
0.05
106.01%
-0.97
2,223.48%
-3.72
282.48%
-1.81
51.37%
-5.44
200.97%
30.06
652.72%
roic
-0.80
-
8.45
1,156.65%
-1.02
112.07%
-0.42
59.04%
0.22
153.41%
-0.50
323.56%
-0.53
7.12%
-0.61
14.21%
-0.63
2.74%
-1.75
179.68%
sales general and administrative to revenue
13.73
-
2.61
80.98%
4.39
67.99%
2.97
32.26%
0.25
91.50%
3.00
1,089.58%
shareholders equity per share
4.44
-
4.07
8.23%
3.93
3.49%
1.59
59.59%
2.86
80.05%
1.97
31.04%
0.59
70.00%
0.72
21.37%
0.27
62.82%
-0.04
116.61%
stock based compensation to revenue
3.89
-
1.03
73.50%
1.52
47.46%
0.58
61.71%
0.03
94.39%
0.29
797.99%
0.40
37.41%
0.79
95.27%
1.70
116.96%
1.19
30.13%
tangible asset value
9.45M
-
53.70M
468.39%
116.40M
116.78%
-19.81M
117.02%
97.30M
591.11%
102.92M
5.78%
-68.85M
166.90%
23.50M
134.14%
-261.10M
1,210.97%
-238.84M
8.53%
tangible book value per share
0.63
-
2.01
220.55%
3.15
56.69%
-0.39
112.47%
1.40
454.63%
0.97
30.50%
-0.52
153.50%
0.10
119.71%
-0.89
966.18%
-0.57
35.69%
working capital
27.15M
-
64.36M
137.03%
110.14M
71.14%
13.57M
87.68%
-49.26M
463.00%
117.94M
339.45%
-47.62M
140.37%
-10.25M
78.48%
33.54M
427.31%
-231.55M
790.45%

All numbers in USD (except ratios and percentages)